|
Volumn 156, Issue 8, 2009, Pages 1216-1217
|
Ezetimibe - New anti-atherogenic properties?
|
Author keywords
Atheroma; Cholesterol absorption; Ezetimibe; Monocyte chemoattractant factor 1; Monocytes; Niemann Pick C1 like 1; Nuclear factor B; Simvastatin
|
Indexed keywords
CHOLESTEROL;
EZETIMIBE;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
NIEMANN PICK C1 LIKE 1 INHIBITOR;
SIMVASTATIN;
UNCLASSIFIED DRUG;
ATHEROGENESIS;
ATHEROMA;
ATHEROSCLEROTIC PLAQUE;
DOSE RESPONSE;
GENE;
HUMAN;
LIPID RAFT;
LIPID STORAGE;
MACROPHAGE;
MONOCYTE;
NOTE;
NPC1L1 GENE;
PRIORITY JOURNAL;
RABBIT;
ANIMALS;
ANTICHOLESTEREMIC AGENTS;
ATHEROSCLEROSIS;
AZETIDINES;
C-REACTIVE PROTEIN;
CELL MOVEMENT;
CHEMOKINE CCL2;
DISEASE MODELS, ANIMAL;
DRUG THERAPY, COMBINATION;
FEMORAL ARTERY;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
INFLAMMATION;
INFLAMMATION MEDIATORS;
LIPIDS;
MACROPHAGES;
MONOCYTES;
NF-KAPPA B;
RABBITS;
SIMVASTATIN;
|
EID: 68749102073
PISSN: 00071188
EISSN: 14765381
Source Type: Journal
DOI: 10.1111/j.1476-5381.2008.00090.x Document Type: Note |
Times cited : (3)
|
References (8)
|